[HTML][HTML] Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation

Y Lu, Z Li, S Zhang, T Zhang, Y Liu, L Zhang - Theranostics, 2023 - ncbi.nlm.nih.gov
Cellular mitophagy means that cells selectively wrap and degrade damaged mitochondria
through an autophagy mechanism, thus maintaining mitochondria and intracellular …

Impact of Mediterranean diet on metabolic syndrome, cancer and longevity

N Di Daniele, A Noce, MF Vidiri, E Moriconi… - …, 2016 - pmc.ncbi.nlm.nih.gov
Obesity symbolizes a major public health problem. Overweight and obesity are associated to
the occurrence of the metabolic syndrome and to adipose tissue dysfunction. The adipose …

[HTML][HTML] ChatGPT and the rise of generative AI: Threat to academic integrity?

DO Eke - Journal of Responsible Technology, 2023 - Elsevier
The emergence of OpenAI's ChatGPT has put intense spotlight on Generative AI (Gen-AI)
systems and their possible impacts on Academic integrity. This paper provides an overview …

The pharmacological regulation of cellular mitophagy

ND Georgakopoulos, G Wells… - Nature chemical biology, 2017 - nature.com
Small molecules are pharmacological tools of considerable value for dissecting complex
biological processes and identifying potential therapeutic interventions. Recently, the …

Inhibition of cancer antioxidant defense by natural compounds

A Sznarkowska, A Kostecka, K Meller… - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
All classic, non-surgical anticancer approaches like chemotherapy, radiotherapy or
photodynamic therapy kill cancer cells by inducing severe oxidative stress. Even tough …

[HTML][HTML] Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells

M Fiorillo, R Lamb, HB Tanowitz, L Mutti… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Atovaquone is an FDA-approved anti-malarial drug, which first became clinically available in
the year 2000. Currently, its main usage is for the treatment of pneumocystis pneumonia …

Salinomycin as a potent anticancer stem cell agent: State of the art and future directions

D Qi, Y Liu, J Li, JH Huang, X Hu… - Medicinal research …, 2022 - Wiley Online Library
Cancer stem cells (CSCs) are a small subpopulation of cells within a tumor that can both self‐
renew and differentiate into other cell types forming the heterogeneous tumor bulk. Since …

Mitochondrial involvement in migration, invasion and metastasis

TV Denisenko, AS Gorbunova… - Frontiers in cell and …, 2019 - frontiersin.org
Mitochondria in addition to be a main cellular power station, are involved in the regulation of
many physiological processes, such as generation of reactive oxygen species, metabolite …

Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo

L Leanza, M Romio, KA Becker, M Azzolini, L Trentin… - Cancer cell, 2017 - cell.com
The potassium channel Kv1. 3 is highly expressed in the mitochondria of various cancerous
cells. Here we show that direct inhibition of Kv1. 3 using two mitochondria-targeted inhibitors …

Salinomycin-loaded gold nanoparticles for treating cancer stem cells by ferroptosis-induced cell death

Y Zhao, W Zhao, YC Lim, T Liu - Molecular pharmaceutics, 2019 - ACS Publications
Cancer stem cells (CSCs) are a subpopulation of tumor cells that exhibit self-renewal,
differentiation, and tumorigenicity. CSCs are highly resistant to the conventional cancer …